FDA: No Change in Role of Neuroscience Director Billy Dunn - Bloomberg, Citing FDA Statement
Go back to FDA: No Change in Role of Neuroscience Director Billy Dunn - Bloomberg, Citing FDA Statement| BIOGEN IDEC Inc. (NASDAQ: BIIB) | Delayed: 201.99 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $201.99 | 52 Week High | $333.65 | |||
| Open | $201.99 | 52 Week Low | $223.02 | |||
| Day High | $201.99 | P/E | 25.86 | |||
| Day Low | $201.99 | EPS | $7.81 | |||
| Volume | 328 | |||||
| Lilly (Eli) & Co. (NYSE: LLY) | Delayed: 732.20 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $732.20 | 52 Week High | $88.16 | |||
| Open | $732.20 | 52 Week Low | $67.88 | |||
| Day High | $732.20 | P/E | 169.49 | |||
| Day Low | $732.20 | EPS | $4.32 | |||
| Volume | 4,373 | |||||
